LFCR vs NXPI · rev $75.5M vs P/E 29, rev $12.27B
Lifecore Biomedical Inc. (LFCR) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
LFCR currently screens at market cap $207.1M. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the LFCR and NXPI stock pages for the full models.
Not investment advice.